Evan Cantor

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Neuro-Oncology · 2022 · First of 32 authors · 103 citations

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy

Neuro-Oncology Advances · 2022 · 53 citations